Kazia Therapeutics Ltd ADR (KZIA)

Kazia Therapeutics Ltd ADR (KZIA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $89.7M; returns 1 day -3.2%, 1 week +7.7%, 1 year +15.9%.

Kazia Therapeutics Limited (KZIA) is an Australian clinical-stage biotechnology company developing novel small-molecule drugs for oncology, with a primary focus on brain cancers and central nervous system (CNS) malignancies.

Groups KZIA belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Healthcare
• CNS Disorders
• Clinical Stage
• Cancer Therapeutics
• Pharmaceuticals
• Drug Discovery
• Life Sciences
• R&D

KZIA financial model: income statement, cash flow and balance sheet